Press Release
Sequantrix signs agreement with Ono Pharma for use of the AI-to-in vivo platform for drug and target evaluation
Press Release
SEQUANTRIX signs agreement with argenx to use the AI-driven DiseaseDecoder and advanced animal models for drug development
Press Release
SEQUANTRIX signs agreement with Chugai to use the AI-driven DiseaseDecoder for drug development
Press Release
SEQUANTRIX Launches Operations
